ORIC Pharmaceuticals, Inc.
ORIC
$10.08
$0.232.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M |
| Total Depreciation and Amortization | 1.19M | 1.15M | 1.11M | 1.07M | 1.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.33M | 15.05M | 12.11M | 10.35M | 9.19M |
| Change in Net Operating Assets | -2.50M | 1.65M | 1.97M | -428.00K | 817.00K |
| Cash from Operations | -120.23M | -115.01M | -112.66M | -108.88M | -99.73M |
| Capital Expenditure | -1.09M | -1.36M | -1.19M | -1.03M | -685.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.33M | 107.81M | 23.33M | 1.47M | -79.77M |
| Cash from Investing | 11.25M | 106.46M | 22.14M | 445.00K | -80.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 135.67M | 1.77M | 126.72M | 126.59M | 126.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -656.00K | -242.00K | -168.00K | -169.00K | -169.00K |
| Cash from Financing | 135.01M | 1.53M | 126.55M | 126.43M | 126.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.03M | -7.03M | 36.02M | 17.99M | -53.85M |